000938:SZSEUnisplendour Corporation Limited Analysis
Data as of 2026-03-17 - not real-time
Latest Price
Risk Level: Medium
Executive Summary
Unisplendour is trading at CNY 24.45, comfortably below its 20‑day (CNY 25.06), 50‑day (CNY 25.45) and 200‑day (CNY 25.77) moving averages, signalling a short‑term bearish bias. However, the MACD histogram has turned positive (0.07) while volume is on an upward trend, and the price sits just above the technical support of CNY 23.23, offering a potential bounce. The RSI at 44.7 suggests the stock is not yet oversold, leaving room for a modest rally. Fundamentally, revenue surged 43% year‑over‑year to CNY 97.5 bn, but margins remain thin (gross 13.5%, operating 4.7%, profit 1.4%) and the balance sheet is strained with a debt‑to‑equity of 125% and net debt exceeding cash. Valuation is mixed: the trailing PE of 49.9 is well above the industry average of 34.4, yet the forward PE of 23.3 and a modest upside of ~30% relative to the DCF fair value suggest limited upside. The dividend yield is low at 0.31% with a payout ratio of 15%, which appears sustainable given the cash position. High 30‑day volatility (34%) and moderate regulatory exposure in China add to the risk profile, while the low beta (≈0.2) keeps market‑wide systematic risk minimal. Overall, the stock presents a short‑term buying opportunity on technical grounds, but investors should remain cautious of the high leverage and valuation premium.
Market Outlook
Short Term
< 1 yearKey Factors
- Bullish MACD histogram with increasing volume
- Price near technical support at CNY 23.23
- Neutral RSI indicating room for upside
Medium Term
1–3 yearsKey Factors
- Strong 43% revenue growth
- High leverage (debt‑to‑equity 125%)
- Valuation near fair value with forward PE 23.3
Long Term
> 3 yearsKey Factors
- Sustained top‑line expansion potential
- Need for debt reduction to improve balance‑sheet health
- Modest dividend yield with sustainable payout
Key Metrics & Analysis
Financial Health
Technical Analysis
Valuation
Risk Assessment
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.